Edition:
United States

Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

18.30USD
11:59am EDT
Change (% chg)

$0.08 (+0.44%)
Prev Close
$18.22
Open
$18.25
Day's High
$18.45
Day's Low
$17.98
Volume
58,842
Avg. Vol
162,722
52-wk High
$31.69
52-wk Low
$12.51

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.609
Mar '18 0.00 -0.432
FY 2017 Dec '17 0.00 -0.371
Sep '17 0.00 -0.235
Jun '17 0.00 -0.246
Mar '17 0.00 -0.184
FY 2016 Dec '16 0.00 -0.134
Sep '16 0.00 -0.146
Jun '16
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 2 0.00 0.00 0.00 --
Quarter Ending Dec-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 4 0.00 0.00 0.00 --
Year Ending Dec-19 4 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Sep-18 3 -0.69 -0.63 -0.78 --
Quarter Ending Dec-18 3 -0.75 -0.64 -0.90 --
Year Ending Dec-18 4 -2.34 -1.85 -2.75 --
Year Ending Dec-19 5 -2.57 -1.86 -3.24 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.14 32.45
P/E High - Last 5 Yrs. -- 42.14 47.46
P/E Low - Last 5 Yrs. -- 23.47 24.76
Beta -- 0.90 0.87
Price to Sales (TTM) -- 4.16 6.31
Price to Book (MRQ) 4.46 3.42 3.81
Price to Tangible Book (MRQ) 4.46 4.91 5.83
Price to Cash Flow (TTM) -- 22.33 23.35
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.87 1.73
Dividend Yield - 5 Year Avg -- 1.54 1.45
Dividend 5 Year Growth Rate -- -8.36 -5.47
Payout Ratio(TTM) -- 49.47 46.56

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.63 8.47
Sales (TTM) vs TTM 1 Yr. Ago -- 4.63 6.75
Sales - 5 Yr. Growth Rate -- 6.94 7.58
EPS (MRQ) vs Qtr. 1 Yr. Ago -147.58 18.82 25.58
EPS (TTM) vs TTM 1 Yr. Ago -131.70 -- --
EPS - 5 Yr. Growth Rate -- 6.45 7.60
Capital Spending - 5 Yr. Growth Rate -- 7.87 8.44

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.19
Current Ratio (MRQ) 26.01 2.92 2.96
LT Debt to Equity (MRQ) 11.66 9.10 11.41
Total Debt to Equity (MRQ) 11.66 11.40 14.25
Interest Coverage (TTM) -- 41.10 35.04

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.36 54.86
Gross Margin - 5 Yr. Avg. -- 53.41 53.37
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.76 15.90
Operating Margin (TTM) -- 13.46 3.68
Operating Margin - 5 Yr. Avg. -- 14.30 10.98
Pre-Tax Margin (TTM) -- 13.83 3.98
Pre-Tax Margin - 5 Yr. Avg. -- 14.60 11.16
Net Profit Margin (TTM) -- 10.47 0.72
Net Profit Margin - 5 Yr. Avg. -- 10.89 7.49
Effective Tax Rate (TTM) -- 20.39 20.36
Effective Tax Rate - 5 Yr. Avg. -- 23.82 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 810,001,932 703,739,345
Net Income/Employee (TTM) -2,176,917 93,508,343 81,128,873
Receivable Turnover (TTM) -- 4.98 5.02
Inventory Turnover (TTM) -- 2.51 3.61
Asset Turnover (TTM) 0.00 0.82 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -61.46 9.91 9.67
Return on Assets - 5 Yr. Avg. -- 11.31 10.83
Return on Investment (TTM) -65.34 12.95 12.63
Return on Investment - 5 Yr. Avg. -- 14.61 13.94
Return on Equity (TTM) -120.58 14.92 14.80
Return on Equity - 5 Yr. Avg. -- 15.84 15.32
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -88.04 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Apellis Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.00 -1.42 44 26
13 Week -24.74 -28.41 10 45
26 Week -25.81 -30.60 18 48
52 Week -- -- -- 37
YTD -16.04 -22.71 38 40
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 58.43%
# of Holders: 112
Total Shares Held: 32,822,472
3 Mo. Net Change: 11,862,437
# New Positions: 42
# Closed Positions: 9
# Increased Positions: 94
# Reduced Positions: 16
# Net Buyers: 78
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.